UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chromatétude (2015) for Lever Harp: Towards a Wider Musical Landscape

Contemporary music review, 2019-11, Vol.38 (6), p.609-623

O'Farrell, Anne-Marie

2019

Volltextzugriff (PDF)

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5699-5708

2002

Volltextzugriff (PDF)

An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients

Clinical cancer research, 2003-11, Vol.9 (15), p.5465-5476

2003

Volltextzugriff (PDF)

IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways

The EMBO journal, 1998-02, Vol.17 (4), p.1006-1018

1998

Volltextzugriff (PDF)

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Molecular cancer therapeutics, 2006-07, Vol.5 (7), p.1774-1782

2006

Volltextzugriff (PDF)

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Blood, 2003-05, Vol.101 (9), p.3597-3605

2003

Volltextzugriff (PDF)

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

BMC cancer, 2003-02, Vol.3 (1), p.3-3, Article 3

2003

Volltextzugriff (PDF)

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

Leukemia research, 2004-07, Vol.28 (7), p.679-689

2004

Volltextzugriff (PDF)

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

Blood, 2004-12, Vol.104 (13), p.4202-4209

2004

Volltextzugriff (PDF)

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

Clinical & experimental metastasis, 2003-01, Vol.20 (8), p.757-766

2003

Volltextzugriff (PDF)

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Blood, 2002-10, Vol.100 (8), p.2941-2949

2002

Volltextzugriff (PDF)

Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5

Journal of leukocyte biology, 1995-05, Vol.57 (5), p.799-803

1995

Volltextzugriff (PDF)

A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657

Blood, 2003-04, Vol.101 (8), p.3188-3197

2003

Volltextzugriff (PDF)

Signaling Pathways Activated in a Unique Mast Cell Line Where Interleukin-3 Supports Survival and Stem Cell Factor Is Required for a Proliferative Response

Blood, 1996-05, Vol.87 (9), p.3655-3668

1996

Volltextzugriff (PDF)

Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs

The EMBO journal, 1995-03, Vol.14 (6), p.1166-1175

1995

Volltextzugriff (PDF)

Stat3-Dependent Induction of p19INK4D by IL-10 Contributes to Inhibition of Macrophage Proliferation

The Journal of immunology (1950), 2000-05, Vol.164 (9), p.4607-4615

2000

Volltextzugriff (PDF)

A portfolio of compositions

O'Farrell, Anne-Marie

2017

Volltextzugriff (PDF)

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker

BMC cancer, 2003-01, Vol.3

2003

Volltextzugriff (PDF)

Synergistic effect of SU11248 with cytarabine or daunombicin on FLT3 ITD-positive leukemic cells

Blood, 2004, Vol.104 (13), p.4202-4209

2004

Volltextzugriff (PDF)

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5699-5708

2002

Volltextzugriff (PDF)

Signalling events elicited by IL-3 and SCF to regulate mast cell survival and proliferation

Cytokine (Philadelphia, Pa.), 1994-09, Vol.6 (5), p.561-561

1994

Volltextzugriff (PDF)

Molecular responses associated with the action of haemopoietic growth factors

O'Farrell, Anne-Marie

1993

Volltextzugriff (PDF)

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12R{beta}1 and a Novel Cytokine Receptor Subunit, IL-23R

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5699

2002

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)
Dissertationen
(2)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(12)
Animals
(10)
Mice
(10)
Hematology
(8)
Biological And Medical Sciences
(7)
Female
(6)
Fms-Like Tyrosine Kinase 3
(6)
Indoles - Pharmacology
(6)
Medical Sciences
(6)
Receptor Protein-Tyrosine Kinases - Antagonists & Inhibitors
(6)
Aged
(5)
Antineoplastic Agents
(5)
Indoles - Therapeutic Use
(5)
Middle Aged
(5)
Oncology
(5)
Pharmacology. Drug Treatments
(5)
Proto-Oncogene Proteins - Genetics
(5)
Pyrroles - Pharmacology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chromatétude (2015) for Lever Harp: Towards a Wider Musical Landscape

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

An Innovative Phase I Clinical Study Demonstrates Inhibition of FLT3 Phosphorylation by SU11248 in Acute Myeloid Leukemia Patients

IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5

A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657

Signaling Pathways Activated in a Unique Mast Cell Line Where Interleukin-3 Supports Survival and Stem Cell Factor Is Required for a Proliferative Response

Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs

Stat3-Dependent Induction of p19INK4D by IL-10 Contributes to Inhibition of Macrophage Proliferation

A portfolio of compositions

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker

Synergistic effect of SU11248 with cytarabine or daunombicin on FLT3 ITD-positive leukemic cells

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Signalling events elicited by IL-3 and SCF to regulate mast cell survival and proliferation

Molecular responses associated with the action of haemopoietic growth factors

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12R{beta}1 and a Novel Cytokine Receptor Subunit, IL-23R

Suchergebnisse filtern